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Abstract Oxidative stress and ferrous metabolism are impor-
tant in the pathogenesis in Parkinson’s disease. In dopaminergic
neurons, several stress proteins are upregulated under oxidative
stress. To clarify this mechanism, we investigated hemin-related
signal transduction and the induction of oxidative stress-related
proteins in SH-SY5Y cells. We identi¢ed phosphatidylinositol
3-kinase (PI3K) and Nrf2 as important molecules in the induc-
tion of heme oxygenase-1, thioredoxin, and peroxiredoxin-I.
PI3K-related signal controlled Nrf2 activation, and conse-
quently, PI3K inhibitors blocked the nuclear translocation of
Nrf2 and induction of stress proteins. These observations sug-
gest that PI3K and Nrf2 are key molecules in maintaining suit-
able conditions under oxidative stress and ferrous metabolism.
/ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Phosphatidyl inositol 3-kinase;
NF-E2-related factor 2; Antioxidant responsive element;
Heme oxygenase-1; Thioredoxin; Peroxiredoxin
1. Introduction
Oxidative stress is one of the most important factors in the
pathogenesis of idiopathic Parkinson’s disease (PD) [1,2]. Be-
cause the accumulation of iron is observed in neurons of the
substantia nigra in the post-mortem brain from PD patients
[3,4], understanding ferrous metabolism and oxidative stress
may be signi¢cant in examining the pathogenesis of PD.
Heme oxygenase-1 (HO-1), which is well known as a stress
protein and antioxidative protein, has been observed in the
nigral neurons of the PD brain [5]. This suggests that neurons
may express HO-1 to alleviate unsuitable conditions. There-
fore, understanding the mechanisms used to induce HO-1
under stressed conditions is important.
HO-1 [6,7], thioredoxin (Trx) [8], and peroxiredoxin-I
(PrxI) are antioxidative proteins that are induced by oxidative
stress. HO-1 is required to catalyze heme to bilirubin and
carbon monoxide in cells under stressed conditions [6,7]. In
addition, a de¢ciency in HO-1 results in a vulnerability of cells
to various stresses and a disorder in ferrous metabolism [9,10].
In fact, bilirubin is well known as a cellular antioxidant, while
carbon monoxide is considered to play a role as a second
messenger [11,12]. These observations suggest that HO-1
may play important cellular roles under stressed conditions.
Trx is a ubiquitous protein with a redox-active disul¢de/di-
thiol in its conserved active site sequence, CGPC [13]. Trx has
been shown to scavenge singlet oxygen and hydroxyl radicals
[14] and hydrogen peroxide in conjunction with peroxiredoxin
[15]. Trx protects cells against cytotoxicity by hydrogen per-
oxide [16] and 1-methyl-4-phenylpyridinium [17]. Trx is in-
duced under stress conditions or [16,18] by speci¢c drugs [19].
Recently, Nrf2 has been reported to act as a common tran-
scription factor in the induction of antioxidative proteins
under stress conditions [20,21]. The inducible expression of
HO-1, Trx, and PrxI is partially controlled by Nrf2 activation
[20^25], and the promoter or enhancer region of each gene
involves antioxidant responsive element (ARE) as a target of
Nrf2.
In this study, we examined the signal associated with the
induction of HO-1, Trx, and PrxI by hemin in human dopa-
minergic neuroblastoma SH-SY5Y cells.
2. Materials and methods
2.1. Cell culture and application of reagents
The human dopaminergic neuroblastoma cell line, SH-SY5Y, was
purchased from ATCC. SH-SY5Y cells were maintained at 37‡C in
5% CO2 in DMEM/F12 medium, supplemented with 10% fetal bovine
serum and 1% penicillin/streptomycin. Culture medium was ex-
changed twice a week during cell growth. For immunoblot analysis
and immunohistochemistry, experiments were carried out using
1U105 cells in six-well culture plates and 200^500 cells in eight-well
chamber slides, respectively.
Hemin dissolved in DMSO was added to the medium. Cells were
incubated for the duration indicated in the ¢gure legends. In order to
determine which signal pathway is important for the activation of
Nrf2, the phosphatidylinositol 3-kinase (PI3K) inhibitors, wortman-
nin (1 WM) (Alomone labs) and LY294002 (10 WM) (Alomone labs),
an Erk inhibitor, PD98059 (10 WM) (Alexis), p38 inhibitor, SB203580
(10 WM) (Alexis), and JNK inhibitor SP600125 (10 WM) (BIOMOL)
were added to the medium at 1 h before hemin administration.
2.2. Immunoblot analyses
For immunoblot analysis, cells were lysed in sodium dodecyl sulfate
(SDS)-sample bu¡er (50 mM Tris^HCl, pH 6.8, 2% SDS, 10% glyc-
erol, 1 mM phenylmethanesulfonyl £uoride, 2 mM EDTA), and de-
natured by boiling at 100‡C for 5 min. The nuclear fraction for Nrf2
analysis was prepared by centrifugation (15 000Ug, 10 min) after lysis
in NP40 bu¡er (0.5% NP40, 1 mM Tris^HCl, pH 7.9, 500 WM dithio-
threitol, 100 WM EDTA), followed by lysis in SDS-sample bu¡er. The
samples were stored at 320‡C until use. Dye and 2-mercaptoethanol
were added to the specimens, and the mixture was boiled just before
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SDS^polyacrylamide gel electrophoresis (SDS^PAGE). Aliquots (20
Wg) were used for SDS^PAGE. Each protein was separated by size on
8^13% polyacrylamide gels, transferred onto a polyvinylidene di£uor-
ide membrane (Hybond-P, Amersham), and the blots were incubated
in phosphate-bu¡ered saline (PBS) containing 0.1% Tween 20 and
either anti-human HO-1 antibody (Santa Cruz), human Trx antibo-
dy(Cosmo), human PrxI antibody (Santa Cruz), human Nrf2 anti-
body (Santa Cruz), Erk or phospho-Erk antibodies (Santa Cruz),
p38 or phospho-p38 antibodies (Santa Cruz), JNK or phospho-JNK
antibodies (Santa Cruz), and PI3K or phospho-PI3K antibodies (San-
ta Cruz). The bound primary antibodies were detected using horse-
radish peroxidase-conjugated secondary antibodies (Amersham) and
ECL detection reagents (Amersham). Total protein content was de-
termined using bicinchoninic acid protein assay reagent (Pierce).
2.3. Immunohistochemistry
For immunohistochemical analyses, cells in eight-well chamber
slides were washed twice with PBS, and ¢xed in 4% paraformalde-
hyde. After incubating in ice-cold 95% ethyl alcohol/1% acetate and
washing with PBS, the cells were incubated with each antibody over-
night at 4‡C, followed with an incubation with FITC-conjugated sec-
ondary antibody (Santa Cruz). For nuclear localization, counterstain-
ing was performed using propione iodide (PI; ICN Biomedical Inc.).
3. Results and discussion
Nuclear translocation is considered to be an important
mechanism for the activation of the transcription factor
Nrf2. Therefore, we examined the nuclear expression of
Nrf2 in the presence of hemin. Western blot analysis of the
nuclear fraction demonstrated the translocation of Nrf2 by
hemin (Fig. 1A,B). The nuclear translocation of Nrf2 medi-
ated by hemin was dose-dependent (Fig. 1B), and a maximal
level was observed at 6 h after hemin administration (Fig.
1A). At 12 h after hemin administration, nuclear Nrf2 level
was lower than that of 6 h suggesting that 12 h is in o¡-peak
of nuclear translocation. These translocations were detected as
100 kDa actin-binding form described by Kang [26]. Immu-
nostaining also showed the translocation of Nrf2 by hemin in
SH-SY5Y cells (Fig. 1C^E). Although Nrf2 was localized out-
side the nuclei under normal conditions (Fig. 1C), Nrf2 was
translocated into PI-labeled nuclei (Fig. 1D,E) at 6 h after
hemin administration.
In order to con¢rm whether antioxidative proteins, which
contain ARE in their promoter or enhancer region, are co-
induced, immunoblot analysis against antioxidative proteins
was performed in cells at a later phase than that of Nrf2
activation. Immunoblotting clearly demonstrated the induc-
tion of HO-1, Trx, and PrxI in SH-SY5Y cells by hemin
administration (Fig. 2). The expression level of HO-1 reached
maximum levels at 12 h after the hemin administration.
Although the expression of Trx and PrxI was observed under
normal conditions to some degree, both proteins reached the
maximum level at 12 h after hemin administration, as did HO-
1 (Fig. 2). The increases of Trx and PrxI were slight compared
with the increase in HO-1 expression.
In order to identify which signal cascade controlled Nrf2
activation, mitogen-activated protein kinases (MAPKs) and
PI3K pathways were investigated. PI3K was phosphorylated
60^120 min after hemin administration (Fig. 3A), whereas
MAPKs were not phosphorylated (Fig. 3B). In addition, the
e¡ects of MAP kinase inhibitors and PI3K inhibitors were
examined (Fig. 4). Neither the nuclear translocation of Nrf2
(Fig. 4A) nor the induction of oxidative stress-related proteins
(data not shown) by hemin was inhibited by the MAPK in-
Fig. 1. Translocation of Nrf2 is induced by hemin administration in
SH-SY5Y cells. A: Immunoblot analyses of Nrf2 in the nuclear
fraction of SH-SY5Y cells. A time course experiment demonstrating
the translocation of Nrf2 to the nucleus is shown. B: Dose^response
of the translocation of Nrf2 by hemin. C: Immunohistochemistry of
Nrf2 in SH-SY5Y cells. Nrf2 is shown labeled with FITC, and is
localized in the extranuclear portion under normal conditions.
D: Translocation of Nrf2 to the nucleus by hemin. Immunohisto-
chemical signal is observed principally in the nucleus at 6 h after
hemin administration. E: PI staining to localize nuclei. PI signal lo-
cation coincides with that of Nrf2 staining in D. Scale bar= 10 Wm.
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Fig. 2. Induction of HO-1, Trx, and PrxI in SH-SY5Y cells by he-
min. A dramatic increase of HO-1 is observed in SY-SY5Y cells.
Immunoblot analysis using HO-1 antibody demonstrates the induc-
tion of HO-1. Maximal induction is observed at 12 h after hemin
administration. Increases in the expression of Trx and PrxI by hem-
in are also shown. Time course immunoblot experiment shows an
upregulation of Trx and PrxI with minor additional induction on
the basal expression level.
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hibitors, PD98059, SB203580, and SP600125. In contrast, the
PI3K inhibitors, wortmannin and LY294002, dramatically in-
hibited both the nuclear translocation of Nrf2 (Fig. 4A) and
induction of oxidative stress proteins (Fig. 4B).
The regulation of antioxidative proteins is required for the
protection of cells under stress conditions. We have shown
that HO-1, Trx, and PrxI are induced in SH-SY5Y cells by
hemin administration. Our present data indicate that the in-
ductions of these antioxidative proteins are controlled by Nrf2
activation, and that the PI3K pathway may play an important
role in the activation of Nrf2. On the other hand, the MAPK
inhibitors, PD98059, SB203580, and SP600125, did not inhibit
the Nrf2 activation by hemin.
Nrf2 and Keap1 have been reported to be the primary
sensors in the cellular response to oxidative stress [27,28].
The cytoplasmic protein, Keap1, interacts with Nrf2 and in-
hibits its nuclear translocation [27,28]. In addition, the disul-
¢de bond in Keap1 is thought to be a sensor for oxidative
conditions [28]. Signals associated with oxidative stress disrupt
the binding between Nrf2 and Keap1, resulting in the trans-
location of Nrf2 into the nucleus [27,28]. In the nucleus, Nrf2
forms a heterodimer with small-Maf protein and activates the
transcription of oxidative stress-related proteins via an ARE
[20,27]. In Nrf2-de¢cient macrophages, the inducible expres-
sion of antioxidative proteins is not observed, suggesting that
Nrf2 may play a signi¢cant role in inducing the transcription
of genes encoding oxidative stress-related proteins [20,27].
In this report, we demonstrated that the PI3K pathway
regulates the Nrf2-dependent inducible expression of HO-1,
Trx, and PrxI. PI3K phosphorylates phosphatidylinositol at
the D-3 position of the inositol ring and has been shown to
form a heterodimer consisting of an 85 kDa and 110 kDa
subunit [29]. The role of PI3K in intracellular signaling has
been underscored by its implication in a plethora of biological
responses such as cell growth, di¡erentiation apoptosis, calci-
um signaling and insulin signaling [30]. Among the down-
stream targets of PI3K are phospholipase C and serine/threo-
nine kinase Akt. Akt/PKB, one of the most well studied
downstream targets of PI3Ks, protects cells from apoptosis
through the phosphorylation and inhibition of the apoptotic
signals [31]. Based on these diverse e¡ects of PI3K, and be-
cause the induction of oxidative stress-inducible proteins is
thought to be a protective response in cells, we were interested
in determining whether PI3K is involved in ARE regulation
[32]. The present experiments clearly demonstrated not only
PI3K phosphorylation, but also the inhibition of Nrf2 activa-
tion by PI3K inhibitors.
Recently, some reports have referred to the association of
Nrf2 nuclear translocation with the induction of antioxidative
proteins [20,27]. These studies indicate that Nrf2 usually binds
to Keap1 in the extranuclear space, and after suitable stimu-
lation, Nrf2 translocates into the nucleus and acts as a tran-
scription factor. Nrf2 forms a heterodimer with small-Maf
and activates ARE. Since ARE is widely conserved in the
enhancer or promoter regions of antioxidative protein genes,
the activation of Nrf2 may induce the expression of ARE-
driven genes [21,33]. Antioxidative proteins, such as the Trx
super families, require mutual oxidation^redox systems be-
tween each other. Therefore, the co-induction of these pro-
teins may be a reasonable mechanism to contribute to the
tolerance of cells to oxidative stress. Ishii, using Nrf2 null
mice, reported that Nrf2 activation associates with an induc-
ible expression, and not a constitutive expression of oxidative
stress-related proteins [20].
In this report, the co-induction of these proteins was shown,
suggesting a reasonable mechanism of oxidative stress protec-
tion exists in SH-SY5Y cells. Clarifying the antioxidative
mechanism associated with PI3K and Nrf2 is important to
understand the resistance of cells to oxidative stress and oxi-
dative stress-involved diseases such as PD.
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Fig. 3. Signal transduction from hemin to Nrf2 is regulated by
PI3K. A: PI3K is phosphorylated by a hemin-derived signal. Immu-
noreactivity is detected using PI3K antibody and phospho-PI3K
antibody. Phosphorylation of PI3K is shown at 60^120 min after
hemin administration. B: MAPKs, Erk1/2, p38, and JNK are not
signi¢cantly phosphorylated by hemin administration.
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Fig. 4. The PI3K inhibitors, wortmannin and LY29004, block the
Nrf2-related uptake of HO-1, Trx, and PrxI under hemin-treated
conditions. A: Immunoblot by Nrf2 antibody of the nuclear frac-
tion. Wortmannin and LY29004 inhibit the hemin-mediated nuclear
translocation of Nrf2. B: Wortmannin and LY29004 inhibit the
hemin-mediated induction of HO-1, Trx and PrxI. PD: PD98059,
SB: SB203580, SP: SP600125, Wort: wortmannin, LY: LY294002.
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